Related Experiment Video
Updated: Mar 17, 2026

10:09
Methods for Evaluating the Role of c-Fos and Dusp1 in Oncogene Dependence
Published on: January 7, 2019
8.8K
Delayed Induction of Proto-Oncogene Expression in B-CLL Cells by Tumor Necrosis Factor
S M Gignac1, M Buschle1, H E Heslop1
1a Royal Free Hospital School of Medicine, Department of Haematology, London, UK.
Leukemia & Lymphoma
|July 27, 2016
Summary
Tumor necrosis factor (TNF) activates oncogenes in B-chronic lymphocytic leukemia (B-CLL) cells. However, this response is delayed compared to other activators, suggesting a unique signaling mechanism.
Area of Science:
- Oncology
- Molecular Biology
- Immunology
Background:
- B-chronic lymphocytic leukemia (B-CLL) is a common lymphoid malignancy.
- Proto-oncogenes like c-fos, c-jun, and c-myc play critical roles in cell signaling and proliferation.
- Tumor necrosis factor (TNF) is a cytokine involved in inflammation and apoptosis.
Purpose of the Study:
- To investigate the effect of TNF on proto-oncogene transcription in B-CLL cells.
- To compare the kinetics of TNF-induced oncogene expression with other signaling pathways.
Main Methods:
- In-vitro treatment of B-CLL cells with TNF.
- Analysis of c-fos, c-jun, and c-myc mRNA expression.
- Comparison with stimulation by phorbol ester TPA and calcium ionophore A23187.
Main Results:
- TNF induced transcription of c-fos, c-jun, and c-myc in B-CLL cells.
- TNF-induced oncogene expression was significantly delayed compared to TPA.
- The phosphoinositol lipid and protein kinase C (PKC) pathway appears involved in TNF signaling.
Conclusions:
- TNF activates proto-oncogenes in B-CLL cells, but with a notable delay.
- This delay may be attributed to a slower activation of key signaling molecules like fos, jun, and myc.
- The precise mechanism underlying TNF's delayed signaling in B-CLL requires further investigation.
More Related Videos
Related Concept Videos
NF-κB-dependent Signaling Pathway
10.2K
The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The...
NF-κB-dependent Signaling Mechanism
The...
10.2K
Cancer-Critical Genes I: Proto-oncogenes
11.8K
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
11.8K
The Intrinsic Apoptotic Pathway
9.1K
Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
9.1K
Targeted Cancer Therapies
9.1K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
9.1K
Cytotoxic T Cells-mediated Immune Response
7.8K
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
7.8K
Mitogens and the Cell Cycle
8.3K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
8.3K

